U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07119424) titled 'Multidisciplinary Dissection of Renal and Metabolic Effects of Glyfozines on Elderly Patients: From Molecular Aspects to Clinical Indications' on July 01.

Brief Summary: The project aims to study the impact of SGLT2i therapy on clinical and biochemical aspects. in elderly. The project will combine different types of data, such as clinical and biological information, and will use advanced Bayesian statistical methods to understand the relationship between risk factors and patient outcomes following treatment with SGLT2 inhibitors.

Study Start Date: Feb. 14

Study Type: OBSERVATIONAL

Condition: Elderly Patients (>65 Years) Diabe...